Goldenwell Biotech Q3 2026 Results: Net Loss of $31.5K, Loss Widens
Goldenwell Biotech Inc. reported a net loss of $86,022 for the nine months ended September 30, 2026, with zero revenue generated during the period. The company faces substantial doubt about its ability to continue as a going concern due to an accumulated deficit of $1,742,138 and limited cash reserves of $788.
- Key figure
- Net loss $31.5K